Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Keith B. Hartman is active.

Publication


Featured researches published by Keith B. Hartman.


Chemical Communications | 2005

Superparamagnetic gadonanotubes are high-performance MRI contrast agents

Balaji Sitharaman; Kyle Kissell; Keith B. Hartman; Lesa A. Tran; Andrei Baikalov; Irene Rusakova; Yanyi Sun; Htet A. Khant; Steven J. Ludtke; Wah Chiu; Sabrina Laus; Éva Tóth; Lothar Helm; Andre E. Merbach; Lon J. Wilson

We report the nanoscale loading and confinement of aquated Gd3+n-ion clusters within ultra-short single-walled carbon nanotubes (US-tubes); these Gd3+n@US-tube species are linear superparamagnetic molecular magnets with Magnetic Resonance Imaging (MRI) efficacies 40 to 90 times larger than any Gd3+-based contrast agent (CA) in current clinical use.


Journal of the American Chemical Society | 2010

Design, Synthesis, and Imaging of an Activatable Photoacoustic Probe

Jelena Levi; Sri-Rajasekhar Kothapalli; Te-Jen Ma; Keith B. Hartman; Butrus T. Khuri-Yakub; Sanjiv S. Gambhir

Photoacoustic tomography is a rapidly growing imaging modality that can provide images of high spatial resolution and high contrast at depths up to 5 cm. We report here the design, synthesis, and evaluation of an activatable probe that shows great promise for enabling detection of the cleaved probe in the presence of high levels of nonactivated, uncleaved probe, a difficult task to attain in absorbance-based modality. Before the cleavage by its target, proteolytic enzyme MMP-2, the probe, an activatable cell-penetrating peptide, Ceeee[Ahx]PLGLAGrrrrrK, labeled with two chromophores, BHQ3 and Alexa750, shows photoacoustic signals of similar intensity at the two wavelengths corresponding to the absorption maxima of the chromophores, 675 and 750 nm. Subtraction of the images taken at these two wavelengths makes the probe effectively photoacoustically silent, as the signals at these two wavelengths essentially cancel out. After the cleavage, the dye associated with the cell-penetrating part of the probe, BHQ3, accumulates in the cells, while the other dye diffuses away, resulting in photoacoustic signal seen at only one of the wavelengths, 675 nm. Subtraction of the photoacoustic images at two wavelengths reveals the location of the cleaved (activated) probe. In the search for the chromophores that are best suited for photoacoustic imaging, we have investigated the photoacoustic signals of five chromophores absorbing in the near-infrared region. We have found that the photoacoustic signal did not correlate with the absorbance and fluorescence of the molecules, as the highest photoacoustic signal arose from the least absorbing quenchers, BHQ3 and QXL 680.


Nano Letters | 2008

Gadonanotubes as Ultrasensitive pH-Smart Probes for Magnetic Resonance Imaging

Keith B. Hartman; Sabrina Laus; Robert D. Bolskar; Raja Muthupillai; Lothar Helm; Éva Tóth; and André E. Merbach; Lon J. Wilson

With their nanoscalar, superparamagnetic Gd(3+)-ion clusters (1 x 5 nm) confined within ultrashort (20-80 nm) single-walled carbon nanotube capsules, gadonanotubes are high-performance T1-weighted contrast agents for magnetic resonance imaging (MRI). At 1.5 T, 37 degrees C, and pH 6.5, the r1 relaxivity (ca. 180 mM(-1) s(-1) per Gd(3+) ion) of gadonanotubes is 40 times greater than any current Gd(3+) ion-based clinical agent. Herein, we report that gadonanotubes are also ultrasensitive pH-smart probes with their r1/pH response from pH 7.0-7.4 being an order of magnitude greater than for any other MR contrast agent. This result suggests that gadonanotubes might be excellent candidates for the development of clinical agents for the early detection of cancer where the extracellular pH of tumors can drop to pH=7 or below. In the present study, gadonanotubes have also been shown to maintain their integrity when challenged ex vivo by phosphate-buffered saline solution, serum, heat, and pH cycling.


Molecular Diagnosis & Therapy | 2008

Detecting and Treating Cancer with Nanotechnology

Keith B. Hartman; Lon J. Wilson; Michael G. Rosenblum

Nanotechnology offers many opportunities for enhanced diagnostic and therapeutic medicine against cancer and other diseases. In this review, the special properties that result from the nanoscale size of quantum dots, metal colloids, superparamagnetic iron oxide, and carbon-based nanostructures are reviewed and interpreted against a background of the structural and electronic detail that gives rise to their nanotechnologic behavior. The detection and treatment of cancer is emphasized, with special attention paid to the biologic targeting of the disease. The future of nanotechnology in cancer research and clinical practice is projected to focus on ‘theranostic’ nanoparticles that are both diagnostic and therapeutic by design.


Small | 2011

Preclinical Evaluation of Raman Nanoparticle Biodistribution for their Potential Use in Clinical Endoscopy Imaging

Cristina Zavaleta; Keith B. Hartman; Zheng Miao; Michelle L. James; Paul Kempen; Avnesh S. Thakor; Carsten H. Nielsen; Robert Sinclair; Zhen Cheng; Sanjiv S. Gambhir

Raman imaging offers unsurpassed sensitivity and multiplexing capabilities. However, its limited depth of light penetration makes direct clinical translation challenging. Therefore, a more suitable way to harness its attributes in a clinical setting would be to couple Raman spectroscopy with endoscopy. The use of an accessory Raman endoscope in conjunction with topically administered tumor-targeting Raman nanoparticles during a routine colonoscopy could offer a new way to sensitively detect dysplastic lesions while circumventing Ramans limited depth of penetration and avoiding systemic toxicity. In this study, the natural biodistribution of gold surface-enhanced Raman scattering (SERS) nanoparticles is evaluated by radiolabeling them with (64) Cu and imaging their localization over time using micropositron emission tomography (PET). Mice are injected either intravenously (IV) or intrarectally (IR) with approximately 100 microcuries (μCi) (3.7 megabecquerel (MBq)) of (64) Cu-SERS nanoparticles and imaged with microPET at various time points post injection. Quantitative biodistribution data are obtained as % injected dose per gram (%ID g(-1)) from each organ, and the results correlate well with the corresponding microPET images, revealing that IV-injected mice have significantly higher uptake (p < 0.05) in the liver (5 h = 8.96% ID g(-1); 24 h = 8.27% ID g(-1)) than IR-injected mice (5 h = 0.09% ID g(-1); 24 h = 0.08% ID g(-1)). IR-injected mice show localized uptake in the large intestine (5 h = 10.37% ID g(-1); 24 h = 0.42% ID g(-1)) with minimal uptake in other organs. Raman imaging of excised tissues correlate well with biodistribution data. These results suggest that the topical application of SERS nanoparticles in the mouse colon appears to minimize their systemic distribution, thus avoiding potential toxicity and supporting the clinical translation of Raman spectroscopy as an endoscopic imaging tool.


EBioMedicine | 2015

Anthropogenic Carbon Nanotubes Found in the Airways of Parisian Children

Jelena Kolosnjaj-Tabi; Jocelyne Just; Keith B. Hartman; Yacine Laoudi; Sabah Boudjemaa; Damien Alloyeau; Henri Szwarc; Lon J. Wilson; Fathi Moussa

Compelling evidence shows that fine particulate matters (PMs) from air pollution penetrate lower airways and are associated with adverse health effects even within concentrations below those recommended by the WHO. A paper reported a dose-dependent link between carbon content in alveolar macrophages (assessed only by optical microscopy) and the decline in lung function. However, to the best of our knowledge, PM had never been accurately characterized inside human lung cells and the most responsible components of the particulate mix are still unknown. On another hand carbon nanotubes (CNTs) from natural and anthropogenic sources might be an important component of PM in both indoor and outdoor air. We used high-resolution transmission electron microscopy and energy dispersive X-ray spectroscopy to characterize PM present in broncho-alveolar lavage-fluids (n = 64) and inside lung cells (n = 5 patients) of asthmatic children. We show that inhaled PM mostly consist of CNTs. These CNTs are present in all examined samples and they are similar to those we found in dusts and vehicle exhausts collected in Paris, as well as to those previously characterized in ambient air in the USA, in spider webs in India, and in ice core. These results strongly suggest that humans are routinely exposed to CNTs.


Chemical Communications | 2008

TiO2 nanoparticles as a soft x-ray molecular probe

Jared M. Ashcroft; Weiwei Gu; Tierui Zhang; Steven M. Hughes; Keith B. Hartman; Cristina Hofmann; Antonios G. Kanaras; David Kilcoyne; Mark A. Le Gros; Yadong Yin; A. Paul Alivisatos; Carolyn A. Larabell

This communication reports the development of a TiO2-streptavidin nanoconjugate as a new biological label for X-ray bio-imaging applications; this new probe, used in conjunction with the nanogold probe, will make it possible to obtain quantitative, high-resolution information about the location of proteins using X-ray microscopy.


Contrast Media & Molecular Imaging | 2010

Serine‐derivatized gadonanotubes as magnetic nanoprobes for intracellular labeling

Amy A. Hassan; Bonita Tak Yee Chan; Lesa A. Tran; Keith B. Hartman; Jeyarama S. Ananta; Yuri Mackeyev; Lingyun Hu; Robia G. Pautler; Lon J. Wilson; Adrian V. Lee

Gadonanotubes (GNTs), which are powerful new T(1)-weighted MRI contrast agents, were derivatized with serine amino acid substituents to produce water-soluble (2 mg ml(-1)) ser-gadonanotubes (ser-GNs) as magnetic nanoprobes for intracellular labeling. The ser-GNTs were used to efficiently label MCF-7 human breast cancer cells (1.5 x 10(9) Gd(3+) ions/cell) with no observable cytotoxicity. Cell pellets derived from the ser-GNT labeled cells give bright T(1)-weighted MR images, confirming that the ser-GNTs are a promising new nanoprobe technology for magnetic cell labeling and possibly for in vivo cellular trafficking.


Advances in Experimental Medicine and Biology | 2007

Carbon Nanostructures as a New High-Performance Platform for MR Molecular Imaging

Keith B. Hartman; Lon J. Wilson

Over the last several years, great interest has developed in the potential use of carbon nanostructures (C60 fullerenes and nanotubes) in medicine. In some cases, medical agents derived from these materials have demonstrated greater efficacy than existing clinical agents in many imaging and therapeutic applications. This chapter provides an overall review of the application of these materials in the area of magnetic resonance imaging (MRI), with an emphasis on their future applications in targeted MR molecular imaging for the early detection of cancer and other life-threatening diseases.


Journal of the American Chemical Society | 2009

Catalytic Synthesis of Amino Acid- and Peptide-Derivatized Gadonanotubes

Yuri Mackeyev; Keith B. Hartman; Jeyarama S. Ananta; Adrian V. Lee; Lon J. Wilson

A new Rh(6)(CO)(16)-catalyzed functionalization of gadonanotube MRI probes offers the opportunity to prepare a number of amino acid and peptide derivatized gadonanotubes under RT conditions, containing, for example, the cyclic RGD peptide for the biological targeting of cancer.

Collaboration


Dive into the Keith B. Hartman's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Adrian V. Lee

Baylor College of Medicine

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Michael G. Rosenblum

University of Texas MD Anderson Cancer Center

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge